5-chloro-2-(3,4-dimethoxy-5-methylanilino)-4-[4-[(dimethylsulfamoylamino)methyl]anilino]pyrimidine
C22H27ClN6O4S — CID 25070986
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-chloro-2-(3,4-dimethoxy-5-methylanilino)-4-[4-[(dimethylsulfamoylamino)methyl]anilino]pyrimidine
5-chloro-2-(3,4-dimethoxy-5-methylanilino)-4-[4-[(dimethylsulfamoylamino)methyl]anilino]pyrimidine (PubChem CID 25070986) has the molecular formula C22H27ClN6O4S and a molecular weight of 507.02 g/mol. Its IUPAC name is 5-chloro-2-(3,4-dimethoxy-5-methylanilino)-4-[4-[(dimethylsulfamoylamino)methyl]anilino]pyrimidine.
Molecular Properties
| Compound Name | 5-chloro-2-(3,4-dimethoxy-5-methylanilino)-4-[4-[(dimethylsulfamoylamino)methyl]anilino]pyrimidine |
|---|---|
| PubChem CID | 25070986 |
| Molecular Formula | C22H27ClN6O4S |
| Molecular Weight | 507.02 g/mol |
| Exact Mass | 506.15 |
| IUPAC Name | 5-chloro-2-(3,4-dimethoxy-5-methylanilino)-4-[4-[(dimethylsulfamoylamino)methyl]anilino]pyrimidine |
| SMILES | COc1cc(Nc2ncc(Cl)c(Nc3ccc(CNS(=O)(=O)N(C)C)cc3)n2)cc(C)c1OC |
| InChI | InChI=1S/C22H27ClN6O4S/c1-14-10-17(11-19(32-4)20(14)33-5)27-22-24-13-18(23)21(28-22)26-16-8-6-15(7-9-16)12-25-34(30,31)29(2)3/h6-11,13,25H,12H2,1-5H3,(H2,24,26,27,28) |
| InChIKey | LURHZDRQRRBCGY-UHFFFAOYSA-N |
| XLogP | 3.84 |
| TPSA | 117.71 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 507.02 |
| LogP ≤ 5 | 3.84 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 25070986 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.